The contract research industry for new drug development grew at an annual rate of 15% to exceed US$20 billion in 2009, with Asia outgrowing the market at an annual 30% growth rate to reach US$1.6 billion.
Although lagging behind its peers, Malaysia is taking steps to change this, with at least 1,000 clinical trials targeted by 2020.
This EPP therefore focuses on developing a supportive clinical research ecosystem that allows for more efficient and higher quality trials.
- In 2014, Lucenxia commenced the first medical device clinical trial for automatic peritoneal dialysis devices in Malaysia, which is targeted for completion by July 2015. Working with eight hospitals, Lucenxia has already completed 29 clinical trials.
- Clinical Research Malaysia extended its service to the private sector by signing an MoU with UCSI University in 2014. It is also in discussions with Prince Court Medical Centre, Institut Jantung Negara (IJN), Nilai Cancer Institute, UPM and UiTM Sungai Buloh to build a potential investigators database.
- In 2014, an MoU was signed to develop a network between Quintiles and Clinical Research Centre to raise the skill sets of study coordinators and investigators. During the year, nine Good Clinical Practice (GCP) courses and one GCP refresher workshop were conducted.
- A Mentor-Mentee programme was extended to the East Coast for the northern and central regions. To date, there are 17 mentors and 64 mentees in three regions.